A prospective trial of preoperative chemotherapy in resectable breast cancer: Predictors of breast-conservation therapy feasibility

[1]  J. Pater.  Treatment of locally advanced breast cancer , 2004, Canadian Medical Association Journal.

[2]  M. Schwaiger,et al.  Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Wolff,et al.  Primary systemic therapy in operable breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  G. Hortobagyi,et al.  Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  G. Hortobagyi,et al.  Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  G. MacGrogan,et al.  Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS). , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  T. Powles,et al.  A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  Anna L. Brown,et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  D. Winchester,et al.  Standards for diagnosis and management of invasive breast carcinoma , 1998, CA: a cancer journal for clinicians.

[10]  A. Seidman.  One-hour paclitaxel via weekly infusion: dose-density with enhanced therapeutic index. , 1998, Oncology.

[11]  D. Wickerham,et al.  Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S E Harms,et al.  Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging , 1996, Cancer.

[13]  S. Singletary,et al.  Locally advanced noninflammatory breast cancer. , 1996, The Surgical clinics of North America.

[14]  J. Thompson,et al.  A phase II study of single agent paclitaxel in patients at first relapse following initial chemotherapy for breast cancer. , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

[15]  B. Asselain,et al.  Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. , 1995, European journal of cancer.

[16]  T. Powles,et al.  Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  V. Semiglazov,et al.  Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  B. Asselain,et al.  Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. , 1994, European journal of cancer.

[19]  J. Hogg.  Magnetic resonance imaging. , 1994, Journal of the Royal Naval Medical Service.

[20]  G. Hortobagyi,et al.  Feasibility of breast‐conservation surgery after induction chemotherapy for locally advanced breast carcinoma , 1992, Cancer.

[21]  Letter to the editor [2] , 1992 .

[22]  L. Mauriac,et al.  Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  G. Hortobagyi,et al.  Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity. , 1991, Annals of surgery.

[24]  A. Luini,et al.  Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. , 1990, Journal of the National Cancer Institute.

[25]  G. Hortobagyi,et al.  The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. , 1989, Archives of surgery.

[26]  T. Shawker,et al.  Mastectomy Following Preoperative Chemotherapy " by Broadwater , 2022 .